Ann Gidner

Ann Gidner

Chief Executive Officer at ZICCUM AB
60 year
Health Technology
Process Industries
Consumer Services

Profile

Ann Ulrika Gidner is currently Chief Executive Officer at Ziccum AB since 2022.
Former roles include Chief Executive Officer at AcuCort AB, Chief Executive Officer at SelectImmune Pharma AB from 2020 to 2022, Director-Sales & Marketing at LANXESS Deutschland GmbH, Life Science Director at Semcon Caran AB, Director-Sales & Business Development at Novozymes Biopharma Sweden AB, Director at SenzaGen AB from 2014 to 2020, Managing Director at Monocl AB, Director-Business Development at Albumedix A, Independent Director at Iconovo AB, Senior Global Business Development Officer at Cambrex Corp., Principal at LANXESS Corp., Principal at Cambrex AB, and Head-CTS Business Unit at Inceptua GmbH.
Education includes graduate and MBA degrees from the University of Lund.

Ann Gidner active positions

CompaniesPositionStart
ZICCUM AB Chief Executive Officer 2022-05-08
THOR MEDICAL Director/Board Member 2025-04-23

Former positions of Ann Gidner

CompaniesPositionEnd
SELECTIMMUNE PHARMA AB (PUBL) Chief Executive Officer 2022-04-26
SENZAGEN AB Director/Board Member 2019-12-31
Sales & Marketing -
CAMBREX CORPORATION Corporate Officer/Principal -
ICONOVO AB Director/Board Member -
See the detail of Ann Gidner's experience

Training of Ann Gidner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

10

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Process Industries

Consumer Services

Cambrex AB

Process Industries

Industrial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services